A5040792665- Childhood Cancer Survivors' Quality of Life
- Palliative Care and End-of-Life Issues
- Obsessive-Compulsive Spectrum Disorders
- Intensive Care Unit Cognitive Disorders
- Family and Patient Care in Intensive Care Units
- Ethics and Legal Issues in Pediatric Healthcare
- Child and Adolescent Psychosocial and Emotional Development
- Ethics in medical practice
- Family and Disability Support Research
- Autism Spectrum Disorder Research
- Neutropenia and Cancer Infections
- Acute Myeloid Leukemia Research
- Cancer survivorship and care
- Reproductive Biology and Fertility
- Child and Adolescent Health
- Infant Development and Preterm Care
- Behavioral and Psychological Studies
- Respiratory Support and Mechanisms
- PI3K/AKT/mTOR signaling in cancer
- Reproductive Health and Technologies
- Cancer Risks and Factors
- Healthcare Quality and Management
- Perfectionism, Procrastination, Anxiety Studies
- Cancer therapeutics and mechanisms
- Psychosomatic Disorders and Their Treatments
Children's Hospital of New Orleans
2023-2024
Ochsner Medical Center
2023-2024
St. Jude Children's Research Hospital
2013-2024
Children's Research Hospital
2015
University of Southern Mississippi
2013
Winona State University
2013
Virginia Tech
2009-2010
Bucknell University
2005
This study examined the efficacy of Collaborative & Proactive Solutions (CPS) in treating oppositional defiant disorder (ODD) youth by comparing this novel treatment to Parent Management Training (PMT), a well-established treatment, and waitlist control (WLC) group. One hundred thirty-four (ages 7–14, 61.9% male, 83.6% White) who fulfilled Diagnostic Statistical Manual Mental Disorders (4th ed.) criteria for ODD were randomized CPS, PMT, or WLC groups. was assessed with semistructured...
The purpose of the current study was to extend research regarding parent-child agreement in assessment anxiety disorders include youth with obsessive-compulsive disorder (OCD). Ninety-three children and adolescents OCD (50 female, 43 male), ages 6 17 years, their parents were administered Anxiety Disorders Interview Schedule for Children. Data obtained from a review records seeking services university-based treatment clinic. Consistent previous on youth, results indicated that is relatively...
Abstract Effective vaccination is now available to prevent human papillomavirus (HPV), the most common sexually transmitted infection and cause of cervical cancer. This study aimed estimate prevalence HPV among childhood cancer survivors identify factors associated with vaccine initiation completion. Mothers daughters ages 9 17 years with/without a history (n = 235, Mage 13.2 years, SD 2.69; n 70, 13.3 2.47, respectively) completed surveys querying completion along sociodemographic, medical,...
Introduction Children with underlying oncologic and hematologic diseases who require critical care services have unique risk factors for developing functional impairments from pediatric post-intensive syndrome (PICS-p). Early mobilization rehabilitation programs offer a promising approach mitigating the effects of PICS-p in oncology patients but not yet been studied this high-risk population. Methods We describe development feasibility implementing an early mobility quality improvement...
The need for effective treatments obsessive-compulsive disorder (OCD) in childhood is evident given that as many 50% of the adults with OCD report symptom onset before age 15. Despite growing evidence supporting efficacy Exposure and Response Prevention (ERP) youth OCD, children seeking services their symptoms often do not receive ERP because difficulties treatment accessibility. Brief time-intensive programs may be a feasible option families who have access to and/or live an area where...
Consistent with the core underpinnings of advocacy within field pediatrics, discipline pediatric psychology places an emphasis on advocating for children through clinical and research efforts as well a systems approach interdisciplinary collaboration partnering others. In current article, role psychologists children's hospitals are highlighted. Various forms models discussed, particularly they relate to individual organizational hospitals, shared other health care providers leadership....
10004 Background: Venetoclax is an orally available BCL-2 antagonist with demonstrated activity in adults newly diagnosed or relapsed acute myeloid leukemia (AML). Here, we describe the first use of venetoclax 1) combination high-dose cytarabine and idarubicin 2) patients 2-22 years old AML. Methods: Patients AML refractory to at least two courses induction therapy were enrolled this Phase 1 study a rolling-six design. All received (240 360 mg/m 2 ) on days 1-28 low-dose (LD: 100 every 12...